NCT01243073 Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia Vera Status COMPLETED Phase PHASE2
NCT01199562 Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01193699 Safety Study of Pegylated Interferon Alpha 2b to Treat Polycythemia Vera Status COMPLETED Phase PHASE1/PHASE2
NCT01053494 Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer Status COMPLETED Phase NA
NCT01038856 Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera Status TERMINATED Phase PHASE2
NCT01014546 Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis Status TERMINATED Phase PHASE1
NCT00940784 Clopidogrel and Aspirin for the Treatment of Polycythemia Vera Status WITHDRAWN Phase PHASE2
NCT00928707 Phase II Study of GIVINOSTAT (ITF2357) in Combination With Hydroxyurea in Polycythemia Vera Status COMPLETED Phase PHASE2
NCT00890747 Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy Status COMPLETED Phase PHASE1
NCT00866762 A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia Status UNKNOWN Phase PHASE2
NCT00745550 A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis Status COMPLETED Phase PHASE1/PHASE2
NCT00715247 Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes Status COMPLETED Phase N/A
NCT00665067 Correlative Biomarker Study in Patients With Myeloproliferative Disorders Status COMPLETED Phase N/A